Related Experiment Videos
[Indications and contraindications for therapy with cardiac glycosides]
Fortschritte Der Medizin
|August 26, 1982
Insights
Cardiac glycosides are indicated for chronic heart failure and certain arrhythmias, but not acute heart failure. Careful consideration of contraindications is essential for safe and effective use in patients with coronary heart disease.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Cardiac glycosides remain relevant for specific cardiovascular conditions.
- Their role in acute cardiac insufficiency has diminished.
Purpose:
- To outline current indications for cardiac glycosides.
- To highlight contraindications and specific use cases in coronary heart disease.
Summary:
- Current indications include manifest and chronic cardiac insufficiency, arrhythmia absoluta, and paroxysmal supraventricular tachycardia.
- Glycosides are not considered primary therapy for acute cardiac insufficiency.
- Contraindications must be recognized, with cautious use in coronary heart disease patients only when cardiac insufficiency is present.
Impact:
- Provides clarity on the appropriate application of cardiac glycosides.
- Emphasizes the importance of patient-specific contraindication assessment.
- Supports evidence-based prescribing practices in cardiology.
Abstract:
Today glycosides have 3 indications: manifest and chronic cardiac insufficiency, arrhythmia absoluta and paroxysmal supraventricular tachycardia. Glycosides are no longer important in the therapy of acute cardiac insufficiency. There are also absolute and relative contraindications which should be recognized; in coronary heart disease glycosides should only be used if there is really a latent of manifest cardiac insufficiency.